Related Experiment Video
Updated: Dec 22, 2025
08:23
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
4.6K
Nitric oxide in heart failure: friend or foe
1Walter Mackenzie Helath Sciences Centre, Cardiology Division of the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. bjugdutt@ualberta.ca
Heart Failure Reviews
|October 16, 2002
Summary
Nitric oxide (NO) exhibits dual effects, acting beneficially at low doses for vascular health and immunity, but becoming deleterious at high doses, potentially causing hypotension and heart failure.
Area of Science:
- Biochemistry
- Physiology
- Pharmacology
Background:
- Nitric oxide (NO) is a molecule with a complex and debated role in biological systems.
- Its effects are often described as either beneficial or harmful, depending on various factors.
Purpose of the Study:
- To elucidate the dose-dependent duality of nitric oxide's biological functions.
- To understand the mechanisms underlying both the beneficial and deleterious effects of NO.
Main Methods:
- Review of existing literature on nitric oxide's physiological and pathological roles.
- Analysis of studies involving nitric oxide donors and their effects at different concentrations.
Main Results:
- Low doses of nitric oxide are crucial for maintaining blood flow and blood pressure.
- Small concentrations of NO also play a protective role against pathogens.
- High doses of NO lead to hypotension, peroxynitrite formation, and contribute to heart failure.
Conclusions:
- The biological impact of nitric oxide is critically dependent on its concentration.
- Understanding NO's dose-response relationship is essential for its therapeutic application and for comprehending its role in disease.
Related Concept Videos
01:30Heart Failure V: Medical Management
156
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
156
01:29Heart Failure II: Pathophysiology
585
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
585
01:28Nitric Oxide Signaling Pathway
6.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.0K
01:16Antianginal Drugs: Nitrates and β-Blockers
1.2K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
810
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
810
01:22Heart Failure Drugs: β-Blockers
674
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
674